All Stories

  1. Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects

    Article • Journal of Medical Virology, November 2020, Wiley

    Dr Elena Criscuolo

  2. Next Generation Vaccines for Infectious Diseases

    Article • Journal of Immunology Research, April 2019, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  3. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects

    Article • Journal of Virology, March 2019, ASM Journals

    Dr Elena Criscuolo

  4. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

    Article • Journal of Immunology Research, March 2019, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  5. Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle

    Article • Antiviral Research, March 2018, Elsevier

    Dr Elena Criscuolo

  6. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

    Article • Antiviral Research, July 2017, Elsevier

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  7. Role and potential therapeutic use of antibodies against herpetic infections

    Article • Clinical Microbiology and Infection, June 2017, Elsevier

    Dr Elena Criscuolo

  8. Bacteriophages and Their Immunological Applications against Infectious Threats

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    Sara Spadini, Dr Elena Criscuolo

  9. Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes

    Article • Drug Discovery Today, April 2016, Elsevier

    Dr Elena Criscuolo

  10. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy

    Article • Antiviral Research, August 2014, Elsevier

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  11. Epitope Mapping by Epitope Excision, Hydrogen/Deuterium Exchange, and Peptide-Panning Techniques Combined with In Silico Analysis

    Article • January 2014, Springer Science + Business Media

    Nicasio Mancini, Dr Elena Criscuolo

  12. JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    Nicasio Mancini, Dr Elena Criscuolo

  13. Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  14. Influenza B-Cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines

    Article • Viruses, November 2012, MDPI AG

    Nicasio Mancini, Dr Elena Criscuolo

  15. Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?

    Article • Viruses, September 2012, MDPI AG

    Nicasio Mancini, PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo